Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Expert Review of Neurotherapeutics|November 5, 2016
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectivesAlberto Gajofatto, Marco Turatti, Maria Donata BenedettiDrug, Healthcare and Patient Safety|December 31, 2015
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisAlberto Gajofatto, Marco Turatti, Salvatore Monaco, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 13, 2010
Long survival and clinical stability in Marburg's variant multiple sclerosisMarco Turatti, Alberto Gajofatto, Francesca Rossi, et al.BMC Neurology|March 29, 2023
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticityAlberto Gajofatto, Nicolò Cardobi, Francesca Gobbin, et al.Journal of the Neurological Sciences|November 16, 2012
Benign course of tumour-like multiple sclerosis. Report of five cases and literature reviewMarco Turatti, Alberto Gajofatto, Maria Rachele Bianchi, et al.Journal of Neurology|April 12, 2011
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP scorePaolo Invernizzi, Laura Bertolasi, Maria Rachele Bianchi, et al.World Journal of Clinical Cases|August 6, 2015
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?Alberto Gajofatto, Maria Donata BenedettiMultiple Sclerosis and Related Disorders|May 8, 2018
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimodMaria Donata Benedetti, Antonio Marangi, Silvia Bozzetti, et al.Archives of Neurology|June 19, 2010
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 casesAlberto Gajofatto, Salvatore Monaco, Michele Fiorini, et al.Expert Opinion on Investigational Drugs|February 20, 2018
Investigational immunosuppressants in early-stage clinical trials for the treatment of multiple sclerosisAlberto Gajofatto, Marco TurattiPageof 11